Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 4;12(1):e0169102.
doi: 10.1371/journal.pone.0169102. eCollection 2017.

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease

Affiliations

Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease

Cristiana Costa Pereira et al. PLoS One. .

Abstract

Inflammation is the driving force in inflammatory bowel disease (IBD) and its link to oxidative stress and carcinogenesis has long been accepted. The antioxidant system of the intestinal mucosa in IBD is compromised resulting in increased oxidative injury. This defective antioxidant system may be the result of genetic variants in antioxidant genes, which can represent susceptibility factors for IBD, namely Crohn's disease (CD) and ulcerative colitis (UC). Single nucleotide polymorphisms (SNPs) in the antioxidant genes SOD2 (rs4880) and GPX1 (rs1050450) were genotyped in a Portuguese population comprising 436 Crohn's disease and 367 ulcerative colitis patients, and 434 healthy controls. We found that the AA genotype in GPX1 is associated with ulcerative colitis (OR = 1.93, adjusted P-value = 0.037). Moreover, we found nominal significant associations between SOD2 and Crohn's disease susceptibility and disease subphenotypes but these did not withstand the correction for multiple testing. These findings indicate a possible link between disease phenotypes and antioxidant genes. These results suggest a potential role for antioxidant genes in IBD pathogenesis and should be considered in future association studies.

PubMed Disclaimer

Conflict of interest statement

Prof. Magro has received fees for speaking engagements from ScheringPlough/MSD, Abbvie, Lab Vitoria, and Dr. Falk Pharma Portugal, and fees for consultancies and honoraria from MSD. The other authors state no conflicts of interest concerning this paper. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

References

    1. Abraham C, Cho JH. Inflammatory Bowel Disease. New England Journal of Medicine. 2009;361(21):2066–78. 10.1056/NEJMra0804647 - DOI - PMC - PubMed
    1. Podolsky DK. Inflammatory Bowel Disease. New England Journal of Medicine. 2002;347(6):417–29. 10.1056/NEJMra020831 - DOI - PubMed
    1. Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease. Immunological reviews. 2005;206:277–95. Epub 2005/07/29. 10.1111/j.0105-2896.2005.00293.x - DOI - PubMed
    1. Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunological reviews. 2005;206:296–305. Epub 2005/07/29. 10.1111/j.0105-2896.2005.00286.x - DOI - PubMed
    1. Hyams JS. Crohn's disease in children. Pediatric clinics of North America. 1996;43(1):255–77. Epub 1996/02/01. - PubMed

LinkOut - more resources